236 related articles for article (PubMed ID: 27529218)
1. Role of Toll-Like Receptor Signaling in the Pathogenesis of Graft-versus-Host Diseases.
Tu S; Zhong D; Xie W; Huang W; Jiang Y; Li Y
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27529218
[TBL] [Abstract][Full Text] [Related]
2. STING negatively regulates allogeneic T-cell responses by constraining antigen-presenting cell function.
Wu Y; Tang CA; Mealer C; Bastian D; Hanief Sofi M; Tian L; Schutt S; Choi HJ; Ticer T; Zhang M; Sui X; Huang L; Mellor AL; Hu CA; Yu XZ
Cell Mol Immunol; 2021 Mar; 18(3):632-643. PubMed ID: 33500563
[TBL] [Abstract][Full Text] [Related]
3. The role of pattern-recognition receptors in graft-versus-host disease and graft-versus-leukemia after allogeneic stem cell transplantation.
Heidegger S; van den Brink MR; Haas T; Poeck H
Front Immunol; 2014; 5():337. PubMed ID: 25101080
[TBL] [Abstract][Full Text] [Related]
4. Toll-Like Receptor Stimulation by MicroRNAs in Acute Graft-vs.-Host Disease.
Zitzer NC; Garzon R; Ranganathan P
Front Immunol; 2018; 9():2561. PubMed ID: 30455702
[TBL] [Abstract][Full Text] [Related]
5. Innate immunity and transplantation tolerance: the potential role of TLRs/NLRs in GVHD.
Shin OS; Harris JB
Korean J Hematol; 2011 Jun; 46(2):69-79. PubMed ID: 21747878
[TBL] [Abstract][Full Text] [Related]
6. Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease.
Mohamed FA; Thangavelu G; Rhee SY; Sage PT; O'Connor RS; Rathmell JC; Blazar BR
Front Immunol; 2021; 12():757836. PubMed ID: 34712243
[TBL] [Abstract][Full Text] [Related]
7. Graft-versus-host disease is independent of innate signaling pathways triggered by pathogens in host hematopoietic cells.
Li H; Matte-Martone C; Tan HS; Venkatesan S; McNiff J; Demetris AJ; Jain D; Lakkis F; Rothstein D; Shlomchik WD
J Immunol; 2011 Jan; 186(1):230-41. PubMed ID: 21098219
[TBL] [Abstract][Full Text] [Related]
8. The primacy of gastrointestinal tract antigen-presenting cells in lethal graft-versus-host disease.
Koyama M; Hill GR
Blood; 2019 Dec; 134(24):2139-2148. PubMed ID: 31697827
[TBL] [Abstract][Full Text] [Related]
9. Acute graft-vs-host disease: pathobiology and management.
Goker H; Haznedaroglu IC; Chao NJ
Exp Hematol; 2001 Mar; 29(3):259-77. PubMed ID: 11274753
[TBL] [Abstract][Full Text] [Related]
10. Graft-versus-host disease: regulation by microbe-associated molecules and innate immune receptors.
Penack O; Holler E; van den Brink MR
Blood; 2010 Mar; 115(10):1865-72. PubMed ID: 20042727
[TBL] [Abstract][Full Text] [Related]
11. Antigen-presenting cell-derived complement modulates graft-versus-host disease.
Kwan WH; Hashimoto D; Paz-Artal E; Ostrow K; Greter M; Raedler H; Medof ME; Merad M; Heeger PS
J Clin Invest; 2012 Jun; 122(6):2234-8. PubMed ID: 22585573
[TBL] [Abstract][Full Text] [Related]
12. Functional Contributions of Antigen Presenting Cells in Chronic Graft-Versus-Host Disease.
Hong C; Jin R; Dai X; Gao X
Front Immunol; 2021; 12():614183. PubMed ID: 33717098
[TBL] [Abstract][Full Text] [Related]
13. Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host disease.
Divito SJ; Aasebø AT; Matos TR; Hsieh PC; Collin M; Elco CP; O'Malley JT; Bækkevold ES; Reims H; Gedde-Dahl T; Hagerstrom M; Hilaire J; Lian JW; Milford EL; Pinkus GS; Ho VT; Soiffer RJ; Kim HT; Mihm MC; Ritz J; Guleria I; Cutler CS; Clark RA; Jahnsen FL; Kupper TS
J Clin Invest; 2020 Sep; 130(9):4624-4636. PubMed ID: 32516138
[TBL] [Abstract][Full Text] [Related]
14. Priming of Allo-HLA-DP-Specific Reactivity from the Naïve T Cell Compartment Is Not Exclusively Mediated by Professional Antigen-Presenting Cells.
Laghmouchi A; Hoogstraten C; Falkenburg JHF; Jedema I
Biol Blood Marrow Transplant; 2020 Jul; 26(7):1257-1265. PubMed ID: 32165326
[TBL] [Abstract][Full Text] [Related]
15. Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation.
Hashimoto D; Chow A; Greter M; Saenger Y; Kwan WH; Leboeuf M; Ginhoux F; Ochando JC; Kunisaki Y; van Rooijen N; Liu C; Teshima T; Heeger PS; Stanley ER; Frenette PS; Merad M
J Exp Med; 2011 May; 208(5):1069-82. PubMed ID: 21536742
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Targets for Improvement of Allogeneic Hematopoietic Stem Cell Transplantation and Graft-vs.-Host Disease.
Tijaro-Ovalle NM; Karantanos T; Wang HT; Boussiotis VA
Front Immunol; 2019; 10():295. PubMed ID: 30891031
[TBL] [Abstract][Full Text] [Related]
17. PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipients.
Hossain MS; Kunter GM; El-Najjar VF; Jaye DL; Al-Kadhimi Z; Taofeek OK; Li JM; Waller EK
PLoS One; 2017; 12(9):e0184254. PubMed ID: 28953925
[TBL] [Abstract][Full Text] [Related]
18. Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives.
Toubai T; Mathewson ND; Magenau J; Reddy P
Front Immunol; 2016; 7():539. PubMed ID: 27965667
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Analysis of the Activation and Proliferation Kinetics and Effector Functions of Human Lymphocytes, and Antigen Presentation Capacity of Antigen-Presenting Cells in Xenogeneic Graft-Versus-Host Disease.
Kawasaki Y; Sato K; Hayakawa H; Takayama N; Nakano H; Ito R; Mashima K; Oh I; Minakata D; Yamasaki R; Morita K; Ashizawa M; Yamamoto C; Hatano K; Fujiwara SI; Ohmine K; Muroi K; Kanda Y
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1563-1574. PubMed ID: 29678638
[TBL] [Abstract][Full Text] [Related]
20. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
Xia G; Truitt RL; Johnson BD
Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
